Quick Answer
MADRIGAL PHARMACEUTICALS, INC. reported Net Income of -$288.28 million for fiscal year 2025.
MADRIGAL PHARMACEUTICALS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$288.28M | +38.1% |
| 2024 | -$465.89M | -24.7% |
| 2023 | -$373.63M | -26.5% |
| 2022 | -$295.35M | -22.1% |
| 2021 | -$241.85M | -19.6% |
| 2020 | -$202.24M | -140.9% |
| 2019 | -$83.95M | -155.9% |
| 2018 | -$32.81M | -5.3% |
| 2017 | -$31.15M | -18.1% |
| 2016 | -$26.39M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$114.19M | -6.8% | -170.1% |
| June 30, 2025 | -$42.28M | +72.2% | +42.3% |
| March 31, 2025 | -$73.24M | +50.4% | +31.5% |
| September 30, 2024 | -$106.96M | -8.3% | +29.6% |
| June 30, 2024 | -$151.97M | -77.1% | -3.0% |
| March 31, 2024 | -$147.54M | -91.9% | -49.4% |
| September 30, 2023 | -$98.74M | -21.6% | -15.1% |
| June 30, 2023 | -$85.80M | -21.3% | -11.6% |
- MADRIGAL PHARMACEUTICALS, INC. showed an increase of +38.1% in Net Income compared to the prior fiscal year.
- Over the 2016–2025 period, MADRIGAL PHARMACEUTICALS, INC.’s net income has declined by 992.5% (from -$26.39 million to -$288.28 million).
- The most recent figure is from MADRIGAL PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: